Duloxetine Hydrochloride API Market

Duloxetine Hydrochloride API Market contains market size and forecasts of Duloxetine Hydrochloride API in global, including the following market information:
Global Duloxetine Hydrochloride API Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Duloxetine Hydrochloride API Market Sales, 2018-2023, 2023-2030, (Tons)
Global top five Duloxetine Hydrochloride API companies in 2022 (%)
The global Duloxetine Hydrochloride API market was valued at million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Purity Above 99% Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Duloxetine Hydrochloride API include Moehs Iberica Sl, MSN Laboratories, Aurobindo Pharma, RL Fine Chem, Alembic Pharmaceuticals, Zydus Lifesciences, Jubilant Generics, Hetero Drugs and Alkem Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Duloxetine Hydrochloride API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Duloxetine Hydrochloride API Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Duloxetine Hydrochloride API Market Segment Percentages, by Type, 2022 (%)
Purity Above 99%
Purity 99%
Purity Below 99%
Global Duloxetine Hydrochloride API Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Duloxetine Hydrochloride API Market Segment Percentages, by Application, 2022 (%)
Tablets
Capsules
Global Duloxetine Hydrochloride API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)
Global Duloxetine Hydrochloride API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Duloxetine Hydrochloride API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Duloxetine Hydrochloride API revenues share in global market, 2022 (%)
Key companies Duloxetine Hydrochloride API sales in global market, 2018-2023 (Estimated), (Tons)
Key companies Duloxetine Hydrochloride API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moehs Iberica Sl
MSN Laboratories
Aurobindo Pharma
RL Fine Chem
Alembic Pharmaceuticals
Zydus Lifesciences
Jubilant Generics
Hetero Drugs
Alkem Laboratories
Esteve Qu?mica SA
SIGNA SA DE CV
Sun Pharmaceutical Industries
Orbion Pharmaceuticals
Wockhardt
Torrent Pharmaceuticals
Mylan Laboratories
Dr. Reddy's Laboratories
Krka
Teva Pharmaceutical Industries
Nosch Labs
Saneca Pharmaceuticals
Shodhana Laboratories
Uni?n Qu?mico Farmac?utica SA
SCI Pharmtech
Shanghai Wonder Pharmacaceutical
Zhejiang Yongtai Technology
HEC Pharm
Zhejiang Liaoyuan Pharmaceutical
Zhejiang Huahai Pharmaceutical